Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This talk outlines contemporary triggers for referral for AF rhythm control, moving beyond rate control alone. It focuses on early disease, symptoms, progression, and prognostic benefit to support timely specialist input.

Speaker: Dr Shouvik Haldar

Dr Shouvik Haldar is a Consultant Cardiologist and Electrophysiologist at Royal Brompton and Harefield hospitals, part of Guy’s & St Thomas’ NHS Foundation Trust, and an Honorary Senior Clinical Lecturer at Imperial College London. He specialises in the management of complex arrhythmias, atrial fibrillation, and device-based therapies. He trained at Guy’s and St Thomas’ Medical School and completed advanced electrophysiology fellowships at Royal Brompton & Harefield Hospitals and at Toronto General Hospital, University of Toronto, where he worked with global leaders in complex ablation and cardiac device therapy.

Dr Haldar leads a growing portfolio of clinical and translational research focused on atrial fibrillation, arrhythmia outcomes phenotyping, and digital health innovation. He is Chief Investigator and senior author on several national and international studies, with particular interest in atrial fibrillation ablation, persistent atrial fibrillation substrates and wearable-based monitoring. Nationally, he serves as Vice President for Education at the British Cardiovascular Society and has led the education portfolio for the past decade. He is also Programme Director for the UK Heart Rhythm Congress, where he plays a leading role in shaping cardiovascular education and workforce development. He is also involved in developing digital training platforms to support cardiology trainees across the UK.

A strong advocate for innovation, prevention, and patient empowerment, Dr Haldar is known for combining evidence-based, personalised care with a forward-thinking approach to clinical research, digital health, and long-term outcomes.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

13:00 – 13:15 – Presentation by Dr Shouvik Haldar

13:15 – 13:25 – Q&A and discussion

13:25 – 13:30 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!